Home Cart Sign in  
Chemical Structure| 149507-26-6 Chemical Structure| 149507-26-6

Structure of 149507-26-6

Chemical Structure| 149507-26-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 149507-26-6 ]

CAS No. :149507-26-6
Formula : C7H8BFO3
M.W : 169.95
SMILES Code : C1=C(F)C(=CC=C1B(O)O)OC
MDL No. :MFCD00807404
InChI Key :IILGLPAJXQMKGQ-UHFFFAOYSA-N
Pubchem ID :2782194

Safety of [ 149507-26-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Computational Chemistry of [ 149507-26-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 2
Num. H-bond acceptors 4.0
Num. H-bond donors 2.0
Molar Refractivity 42.72
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

49.69 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.9
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.07
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.43
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.32
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.19

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.7
Solubility 3.4 mg/ml ; 0.02 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.53
Solubility 5.03 mg/ml ; 0.0296 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.69
Solubility 3.48 mg/ml ; 0.0205 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.7 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.9

Application In Synthesis of [ 149507-26-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 149507-26-6 ]

[ 149507-26-6 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 1445-39-2 ]
  • [ 149507-26-6 ]
  • [ 890021-33-7 ]
YieldReaction ConditionsOperation in experiment
Example 38; 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-N- phenylpyrimidin-2-amine; Step 1: Preparation of 5- (3-fluoro-4-methoxgammaphengammal) pyrimidin-2- amine; In a 500 mL round bottom flask under N2, 3-fluoro-4- methoxyphenylboronic acid (5.0 g, 29.4 mmol) and 5-iodopyrimidin- 2-amine (5.5 g, 24.9 mmol) were mixed. Toluene (100 mL) , EtOH (40 mL) and H2O (20 mL) were added, followed by the addition of Na2CO3 (3.0 g, 24.2 mmol). A stream of N2 was bubbled through the mixture for 5 min before the catalyst Pd(PPh)4 (0.30 g, 0.26 mmol) was added. The mixture was heated at 80 C under N2 for 20 h whereby it was cooled to RT. A solution of NaOH (5 N, 10 mL) was added to the mixture and stirring was continued for 10 min. The mixture was filtered and the solid was washed with H2O (3 x 10 mL) , followed by a mixture of hexanes - EtOAc (1:1, 30 mL) . The solid was dried in the air to give the title compound. MS (ESI pos. ion) m/z: 220. CaIc'd for C11H10FN3O: 219.08.
  • 2
  • [ 55305-43-6 ]
  • [ 149507-26-6 ]
  • [ 331-62-4 ]
  • 3
  • [ 261953-36-0 ]
  • [ 149507-26-6 ]
  • 6-(3-fluoro-4-methoxyphenyl)-1H-indazole [ No CAS ]
  • 4
  • [ 261953-36-0 ]
  • [ 149507-26-6 ]
  • 6-(3-fluoro-4-hydroxyphenyl)-1H-indazole [ No CAS ]
  • 5
  • [ 885588-14-7 ]
  • [ 149507-26-6 ]
  • methyl 5-fluoro-2-(3-fluoro-4-methoxyphenyl)isonicotinate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; caesium carbonate; In 1,4-dioxane; at 100℃; for 2.0h;Inert atmosphere; A suspension of <strong>[885588-14-7]methyl 2-bromo-5-fluoroisonicotinate</strong>(1.0 g, 4.27 mmol), (3-fluoro-4- methoxyphenyl)boronic acid (1.089 g, 6.41 mmol) , Cs2CO3 (2.78 g, 8.55 mmol) and PdCl2(dppf).CH2Cl2 adduct (0.349 g, 0.427 mmol) in dioxane (10 mL) was stirred at 100 C under Ar for 2 hr. Then the mixture was diluted with water, extracted with EtOAc, the organic layer was dired over Na2SO4, filtered and concentrated in vacuum.The residue was purified by CombinFlash (PE/EA, EA: 20~40% for 50mins) to afford methyl 5-fluoro-2-(3-fluoro-4- methoxyphenyl)isonicotinate (Intermediate D).1H NMR (400 MHz, DMSO-d6) d 8.79 (t ,1H), 8.24 (t ,1H), 7.95- 7.87 (m ,2H), 7.27 (t ,3H), 3.92 (d ,6H). LC-MS: [M+H]+ = 279.9.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 149507-26-6 ]

Fluorinated Building Blocks

Chemical Structure| 352303-67-4

A193379 [352303-67-4]

(2-Fluoro-3-methoxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 182344-14-5

A146892 [182344-14-5]

(3-Fluoro-4-hydroxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 208641-98-9

A131177 [208641-98-9]

(3,5-Difluoro-4-methoxyphenyl)boronic acid

Similarity: 0.91

Chemical Structure| 187804-79-1

A104488 [187804-79-1]

(3-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid

Similarity: 0.88

Chemical Structure| 212386-71-5

A168155 [212386-71-5]

(4-Ethoxy-2,3-difluorophenyl)boronic acid

Similarity: 0.88

Organoborons

Chemical Structure| 352303-67-4

A193379 [352303-67-4]

(2-Fluoro-3-methoxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 182344-14-5

A146892 [182344-14-5]

(3-Fluoro-4-hydroxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 208641-98-9

A131177 [208641-98-9]

(3,5-Difluoro-4-methoxyphenyl)boronic acid

Similarity: 0.91

Chemical Structure| 187804-79-1

A104488 [187804-79-1]

(3-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid

Similarity: 0.88

Chemical Structure| 212386-71-5

A168155 [212386-71-5]

(4-Ethoxy-2,3-difluorophenyl)boronic acid

Similarity: 0.88

Aryls

Chemical Structure| 352303-67-4

A193379 [352303-67-4]

(2-Fluoro-3-methoxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 182344-14-5

A146892 [182344-14-5]

(3-Fluoro-4-hydroxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 208641-98-9

A131177 [208641-98-9]

(3,5-Difluoro-4-methoxyphenyl)boronic acid

Similarity: 0.91

Chemical Structure| 187804-79-1

A104488 [187804-79-1]

(3-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid

Similarity: 0.88

Chemical Structure| 212386-71-5

A168155 [212386-71-5]

(4-Ethoxy-2,3-difluorophenyl)boronic acid

Similarity: 0.88

Ethers

Chemical Structure| 352303-67-4

A193379 [352303-67-4]

(2-Fluoro-3-methoxyphenyl)boronic acid

Similarity: 0.92

Chemical Structure| 208641-98-9

A131177 [208641-98-9]

(3,5-Difluoro-4-methoxyphenyl)boronic acid

Similarity: 0.91

Chemical Structure| 187804-79-1

A104488 [187804-79-1]

(3-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid

Similarity: 0.88

Chemical Structure| 212386-71-5

A168155 [212386-71-5]

(4-Ethoxy-2,3-difluorophenyl)boronic acid

Similarity: 0.88

Chemical Structure| 850589-53-6

A150640 [850589-53-6]

(3-Ethoxy-5-fluorophenyl)boronic acid

Similarity: 0.88